CONMED Corporation (CNMD)
CONMED Corporation R&D Expense: 7.095M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CNMD R&D Expense Rankings
| Overall | 39th percentile | 1065 of 1764 |
| Sector | 42nd percentile | 238 of 413 in Healthcare |
| Industry | 40th percentile | 42 of 70 in Medical Appliances & Equipment |
CNMD R&D Expense Range, Past 5 Years
| Minimum | 6.441M | Jun 2010 |
| Maximum | 8.689M | Jun 2008 |
| Average | 7.657M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these CNMD related companies
CNMD News
Listen to $CNMD CONMED at Deutsche Bank AG Health Care Conference - live at 08:40 AM, ondemand after - http://stks.co/3juP
about 19 days ago by earningscast
about 19 days ago by earningscast
Listen to $CNMD Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3Wkl
about 32 days ago by earningscast
about 32 days ago by earningscast
$CNMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3I4t
about 48 days ago by MarketBrief
about 48 days ago by MarketBrief
CONMED Corporation to Announce First Quarter 2012 Financial Results on April 26, 2012
Apr 05, 7:00AM Marketwire
Apr 05, 7:00AM Marketwire
CONMED Corporation to Present at the 11th Annual Needham Healthcare Conference
Mar 27, 7:00AM Marketwire
Mar 27, 7:00AM Marketwire
CONMED Initiates Quarterly Dividend, Yields 2%: http://stks.co/2coz $CNMD
about 88 days ago by DynamicDividend
about 88 days ago by DynamicDividend
CONMED Corporation Announces Cash Dividend Policy and Declares Initial Quarterly Cash Dividend
Feb 29, 6:30PM Marketwire
Feb 29, 6:30PM Marketwire
Needham & Company Reiterates a 'Buy' on CONMED (CNMD); Setting Positive Tone for 2012
Feb 16, 7:47AM Street Insider
Feb 16, 7:47AM Street Insider
Listen to $CNMD Q4 2011 earnings call (EPS 0.46 vs est 0.4) - live at 10:00 AM, ondemand after - http://stks.co/2PyJ
about 103 days ago by earningscast
about 103 days ago by earningscast
$CNMD Reports Q4 EPS $0.46 vs $0.40 Est; Revenues $185.6M vs $184.97M Est
about 103 days ago by Benzinga
about 103 days ago by Benzinga
Conmed Corp (CNMD) Tops Q4 EPS by 6c; Boosts FY12 Outlook; Guides Q112
Feb 15, 7:06AM Street Insider
Feb 15, 7:06AM Street Insider
CONMED Corporation Announces Fourth Quarter and Year 2011 Financial Results
Feb 15, 7:00AM Marketwire
Feb 15, 7:00AM Marketwire
CONMED Corporation Launches New Products at 2012 Annual American Academy of Orthopaedic Surgeons Meeting
Feb 07, 7:00AM Marketwire
Feb 07, 7:00AM Marketwire
CONMED Corporation to Present at the 2012 Canaccord Genuity Musculoskeletal Conference
Feb 01, 7:00AM Marketwire
Feb 01, 7:00AM Marketwire
CONMED Corporation to Announce Fourth Quarter 2011 Financial Results on February 15, 2012
Jan 10, 7:00AM Marketwire
Jan 10, 7:00AM Marketwire
Listen to $CNMD at piper jaffray health care conference - live at 02:30 PM, ondemand after - http://stks.co/1KKv
about 180 days ago by earningscast
about 180 days ago by earningscast
$CNMD http://chart.ly/hkmlsbe High short interest stock breaking out.
about 476 days ago by stockbee
about 476 days ago by stockbee
$CHS, $VZ, $DTO, $CNMD, $UTI, $III, $QID stocks hit new short-term lows today, how low/high do they usually go? http://tinyurl.com/68mown
about 1239 days ago by BreakoutStocks
about 1239 days ago by BreakoutStocks
Most compelling action at mid-session: $APA & $WAG to the upside and $AGLT & $CNMD to the downside.
about 1239 days ago by optionmonster
about 1239 days ago by optionmonster
Trading radar courtesy of @TradeIdeas: $SNV, $BKS, $ICE, $DRYS, $SLT, $OSK, $CNMD.
about 1239 days ago by StockTickr
about 1239 days ago by StockTickr
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CNMD | 27.23 | -0.10 | -0.37% | 762.71M |
| CNL | 40.93 | +0.25 | +0.61% | 2.489B |
| CNIT | 1.08 | -0.03 | -2.70% | 29.80M |
| CNI | 81.06 | -0.91 | -1.11% | 35.69B |
| CNH | 39.76 | -0.77 | -1.90% | 9.531B |
| CNGL | 0.3801 | +0.00 | +0.00% | 14.03M |
| CLS | 7.57 | +0.01 | +0.13% | 1.496B |
| CLRO | 3.75 | +0.00 | +0.00% | 34.09M |
| CLR | 75.95 | +1.53 | +2.06% | 13.74B |
| CLNY | 16.79 | +0.09 | +0.54% | 555.92M |
